Hidradenitis suppurativa: pathogenesis, clinical presentation, epidemiology, and comorbid associations
- PMID: 33890304
- DOI: 10.1111/ijd.15579
Hidradenitis suppurativa: pathogenesis, clinical presentation, epidemiology, and comorbid associations
Abstract
Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that is clinically defined by lesions ranging from painful, deep seated nodules to abscesses, draining sinus tracts, and ultimately, irreversible fibrotic scars. While the etiology remains unclear, a number of mechanisms ranging from genetics to aberrations of the immune system have been proposed. In addition, HS has a number of associations and may occur in conjunction with several diseases that span a host of medical specialties. The estimated prevalence ranges are from 1% to 4%; however, a large degree of under-reporting and misdiagnosis of this condition likely underestimates its true clinical significance. The debilitating consequences of missed diagnoses or improper management leads to severe pain and irreversible cutaneous manifestations (i.e., fistulae, sinus tracts, disfiguring scarring). HS has been found to significantly impair patients' quality of life to a greater degree when compared with other skin conditions. Early recognition and treatment are critical for a favorable prognosis, and diagnostic delays may be related to variable presentations within numerous comorbidities. Here we provide an in-depth, clinical-based review of HS, highlighting the clinical presentation, pathophysiology, grading systems, epidemiology, and comorbidities, in hopes of shedding light on an often misunderstood disease and ultimately moving closer to a more conclusive understanding of its various presentations and association.
© 2021 the International Society of Dermatology.
Similar articles
-
Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis.J Am Acad Dermatol. 2020 May;82(5):1045-1058. doi: 10.1016/j.jaad.2019.08.090. Epub 2019 Oct 9. J Am Acad Dermatol. 2020. PMID: 31604104 Review.
-
Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life.J Eur Acad Dermatol Venereol. 2021 Jan;35(1):50-61. doi: 10.1111/jdv.16677. Epub 2020 Jul 16. J Eur Acad Dermatol Venereol. 2021. PMID: 32460374 Review.
-
Hidradenitis Suppurativa: A Frequently Missed Diagnosis, Part 1: A Review of Pathogenesis, Associations, and Clinical Features.Adv Skin Wound Care. 2015 Jul;28(7):325-32; quiz 333-4. doi: 10.1097/01.ASW.0000465674.34810.e9. Adv Skin Wound Care. 2015. PMID: 26080019 Review.
-
Pediatric Hidradenitis Suppurativa: An Overview.Skin Therapy Lett. 2025 Jan;30(1):1-4. Skin Therapy Lett. 2025. PMID: 39814056 Review.
-
Hidradenitis suppurativa: Epidemiology and scope of the problem.J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S4-7. doi: 10.1016/j.jaad.2015.07.052. J Am Acad Dermatol. 2015. PMID: 26470614 Review.
Cited by
-
Plant Antimicrobial Peptides as Potential Tool for Topic Treatment of Hidradenitis Suppurativa.Front Microbiol. 2021 Dec 13;12:795217. doi: 10.3389/fmicb.2021.795217. eCollection 2021. Front Microbiol. 2021. PMID: 34966375 Free PMC article. Review.
-
Impact of Psoriasis and Hidradenitis Suppurativa in Pregnancy, a Systematic Review.J Clin Med. 2021 Dec 15;10(24):5894. doi: 10.3390/jcm10245894. J Clin Med. 2021. PMID: 34945189 Free PMC article. Review.
-
The Pathogenesis and Treatment of Hidradenitis Suppurativa.Cureus. 2023 Nov 25;15(11):e49390. doi: 10.7759/cureus.49390. eCollection 2023 Nov. Cureus. 2023. PMID: 38146560 Free PMC article. Review.
-
Prevalence of Hidradenitis Suppurativa in Serbia: Validation of a Screening Questionnaire.Dermatology. 2025 Jul 7:1-6. doi: 10.1159/000539877. Online ahead of print. Dermatology. 2025. PMID: 40623370 Free PMC article.
-
Biosensing circulating MicroRNAs in autoinflammatory skin diseases: Focus on Hidradenitis suppurativa.Front Genet. 2024 Apr 9;15:1383452. doi: 10.3389/fgene.2024.1383452. eCollection 2024. Front Genet. 2024. PMID: 38655054 Free PMC article.
References
-
- Kelly G, Sweeney CM, Tobin A-M, et al. Hidradenitis suppurativa: the role of immune dysregulation. Int J Dermatol 2014; 53: 1186-1196.
-
- Nguyen TV, Damiani G, Orenstein L, et al. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J Eur Acad Dermatol Venereol 2021; 35: 50-61.
-
- Alikhan A, Lynch P, Eisen D. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol 2009; 60: 539-561.
-
- Habif T. Clinical Dermatology: A Color Guide to Diagnosis and Therapy, 7. Elsevier, 2016: 215-263.
-
- Jørgensen A, Thomsen S, Karmisholt K, et al. Clinical, microbiological, immunological and imaging characteristics of tunnels and fistulas in hidradenitis suppurativa and Crohn’s disease. Exp Dermatol 2019; 29: 118-123.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical